Zenocutuzumab (MCLA-128) is a humanized antibody targeting the extracellular domains of HER2 and HER3. It can be used for research on tumors driven by NRG1 gene rearrangement.
Purity:
97.00%
CAS Number:
[1969309-56-5]
Target:
EGFR|||HER
* VAT and and shipping costs not included. Errors and price changes excepted